(Q37776361)

English

Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls.

scientific article published on 26 July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

based on heuristic

inferred from title

Vladimir Tolmachev

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Sharon Stone-Elander

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

26 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

992-1000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Novel antibodies as anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring predominantly cytostatic treatment response with 18F-FDG PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to EGF-R (erbB-1) and VEGF-R modulating agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and application of Hsp90 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biomarkers in cancer staging, prognosis and treatment selection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing epidermal growth factor receptor expression in tumours: what is the value of current test methods?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing tumor response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The lessons of GIST--PET and PET/CT: a new paradigm for imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

3'-deoxy-3'-[18F]fluorothymidine positron emission tomography is a sensitive method for imaging the response of BRAF-dependent tumors to MEK inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

[18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-invasive PET imaging of EGFR degradation induced by a heat shock protein 90 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Imaging of HER-2 overexpression in tumors for guiding therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical characterisation of 111In-DTPA-trastuzumab.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

PET of EGFR antibody distribution in head and neck squamous cell carcinoma models

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Imaging liver metastases of colorectal cancer patients with radiolabelled bevacizumab: Lack of correlation with VEGF-A expression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel method of 18F radiolabeling for PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Technetium-99m labeled epidermal growth factor-tumor imaging in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo tumor angiogenesis imaging with site-specific labeled (99m)Tc-HYNIC-VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative PET imaging of VEGF receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Engineered affinity proteins--generation and applications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Update: affibody molecules for molecular imaging and therapy for cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and preclinical evaluation of [(11)C]PAQ as a PET imaging tracer for VEGFR-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular imaging of epidermal growth factor receptor expression-activity at the kinase level in tumors with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Positron emission tomography (PET) imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970088-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(10)70088-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20667780%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37776361&oldid=1417654091"